JHC 0.00% $1.40 japara healthcare limited

From the report: EBITDA increased to $29,055,000 for the half...

  1. 58 Posts.
    lightbulb Created with Sketch. 2
    From the report:

    EBITDA increased to $29,055,000 for the half year, up $932,000 on the prior comparative period. EBITDA was impacted by a number of costs incurred in the half year that were outside, or greater than, the normal course of business. These costs included organisational restructuring costs and non-recurring marketing expenditure. The Group continued to actively manage staff costs having regard to increasing resident needs, facility ramp-ups and acquisition integration.
    EBIT and profit attributable to members of the parent entity were $22,335,000 and $14,633,000 respectively, both down on the prior comparative period due to an increase in depreciation, financing costs required to fund growth and a one-off tax benefit received last year.
 
watchlist Created with Sketch. Add JHC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.